A Game-Changer for Heart Health A major study found that patients who took Semaglutide reduced their risk of major heart events, such as heart attacks and strokes, by 20% compared to those who didnt take the medication
Chip snacking among GLP-1 users has been trending down for the past year, but has managed to stay ahead of chocolate until this quarter
For obesity management, NICE technology appraisals recommend liraglutide 3.0 mg or semaglutide 2.4 mg only as part of a specialist weight management service for adults with a BMI of 35 kg/m (or 32.5 kg/m for people from certain ethnic backgrounds) and at least one weight-related comorbidity
May 21, 2026: Eli Lilly announced TRIUMPH-1 topline results in adults with obesity or overweight without diabetes
Where the anti-obesity benefit is included in the employer plan, Harvard Pilgrim requires prior authorization with BMI 30 or higher (or 27 with a weight-related comorbidity such as hypertension, T2D, dyslipidemia, or sleep apnea), documented lifestyle program participation, and demonstrated weight-loss progress for renewal
